Each year on World Cancer Day, we take a moment to reflect on how far we’ve come in the fight against cancer and how much work still lies ahead.
This year’s American Cancer Society Cancer Statistics, 2026 report brings a historic milestone worth celebrating: for the first time ever, 70% of people diagnosed with cancer in the United States now survive at least five years after their diagnosis. That’s a remarkable improvement from just 50% in the mid-1970s, and it’s a testament to decades of relentless progress in cancer research, prevention, early detection, and treatment.
These gains reflect transformative advances across many types of cancer. Survival rates have risen dramatically for once-devastating diseases such as myeloma, liver cancer, and lung cancer, and improvements continue across multiple stages of disease. Early detection and coordinated care have saved countless lives and turned many cancers into manageable conditions.
However, as we honor the progress, we must also recognize the challenges that remain, particularly with pancreatic cancer. Despite modest advances, the five-year survival rate for pancreatic cancer lingers near just 13%, making it one of the deadliest common cancers. Unlike breast or colorectal cancers, which benefited enormously from early-screening programs and sustained research investment, pancreatic cancer is too often diagnosed at a late stage when curative treatment is no longer possible.
That stark reality is precisely why the PRECEDE Consortium exists. PRECEDE is the world’s only global initiative exclusively dedicated to early detection of pancreatic cancer, with a bold mission to move survival rates from the current ~13% toward 50%. By advancing early detection tools and fostering collaboration across research, clinical practice, and public health, PRECEDE is working to change the story for people with pancreatic cancer, because early detection saves lives.
On World Cancer Day, we honor the triumphs in cancer care and acknowledge the work still to be done. We celebrate the achievements that have brought survival rates to unprecedented levels and we recommit ourselves to tackling cancers that remain formidable.
Let this World Cancer Day be a moment of hope and a reminder that early detection, research, and advocacy matter. Together, we can continue pushing the boundaries of what’s possible.
